Home  |  
Style  |  
Sitemap  |  
Lund University
 

Literature references 2005-

2012

  1. Pedersen HL, Fangel JU, McCleary B, Ruzanski C, Rydahl MG, Ralet M-C, Farkas V, von Schantz L, Marcos SE, Andersen MCF, Field R, Ohlin M, Knox JP, Clausen MH, Willats WGT (2012) Versatile high-resolution oligosaccharide microarrays for plant glycobiology and cell wall research. J Biol Chem (in press). (Abstract)
  2. Sandström A, Andersson R, Segersvärd R, Löhr M, Borrebaeck CAK, Wingren C (2012) Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures. Proteomics Clin Appl (in press) (Abstract)
  3. Nordström L, Andréasson U, Jerkeman M, Dictor M, Borrebaeck C, Ek S (2012) Expanded clinical and experimental use of SOX11 - using a monoclonal antibody. BMC Cancer 12, 269. (Abstract)
  4. Hertwig F, Meyer K, Braun S, Ek S, Spang R, Pfenninger CV, Artner I, Prost G, Chen X, Biegel JA, Judkins AR, Englund E, Nuber UA (2012) Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells. Cancer Res (in press) (Abstract)
  5. Borrebaeck CAK (2012) Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information? Proteomics Clin Appl (in press) (Abstract)
  6. Olsson N, James P, Borrebaeck CAK, Wingren C (2012) Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry. Mol Cell Proteomics (in press). (Abstract)
  7. Johansson H, Albrekt AS, Borrebaeck CAK, Lindstedt M (2012) The GARD assay for assessment of chemical skin sensitizers. Toxicol In Vitro (in press)
  8. Broos S,  Sandin LC, Apel J, Tötterman TH, Akagi T, Akashi M,Borrebaeck CAK, Ellmark P, Lindstedt M (2012) Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles. Biomaterials (in press). (Abstract)
  9. Kirik U, Cifani P, Albrekt AS, Lindstedt M, Heyden A, Levander F (2012) Multi-model pathway enrichment methods for functional evaluation of expression regulation (FEvER). J Proteome Res (in press) (Abstract)
  10. von Schantz L, Håkansson M, Logan DT, Walse B, Österlin J, Nordberg-Karlsson E, Ohlin M (2012) Structural basis for carbohydrate binding specificity - a comparative assessment of two engineered carbohydrate binding modules. Glycobiology 22, 948-961. (Abstract)
  11. Wingren C, Sandström A, Segersvärd R, Carlsson A, Andersson R, Löhr M, Borrebaeck CAK (2012) Identification of serum biomarker signatures associated with pancreatic cancer. Cancer Res 72, 2481-2490. (Abstract)
  12. Carlsson F, Trilling M, Perez F, Ohlin M (2012) A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus. J Immunol Methods 376, 69-78. (Abstract)
  13. Kristensson M, Olsson K, Carlson J, Wullt B, Sturfelt G, Borrebaeck CAK, Wingren C (2012) Design of recombinant antibody microarrays for urinary proteomics. Proteomics Clin App 6, 291-296. (Abstract)
  14. Brodin E, Ohlin M, Lindén J (2012) Mentorship, supervision and learning experience in PhD education. Stud High Educ (in press) (Abstract) [Epub Sept 26, 2011]

2011

  1. Lindstedt M, Nelissen I, Gibbs S, Borrebaeck CAK (2011) Mimicking the immunoregulatory properties of primary dendritic cells in vitro − A rational approach to design a test system.Chapter 5, page 67-86. In: Progress towards novel testing strategies for in vitro assessment of allergens. (Eds. Roggen EL, Weltzien HU, Hermans H), Transworld Research Network, Kerala, India, pp. 67-86.
  2. Corsini E, Aeby P, Python F, Nelissen I, Kjær T, Gibbs S, dos Santos G, Lindstedt M, Borrebaeck C, Roggen E (2011) The use of myeloid cell lines for the identification of allergens. In: Progress towards novel testing strategies for in vitro assessment of allergens. (Eds. Roggen EL, Weltzien HU, Hermans H), Transworld Research Network, Kerala, India, pp. 103-116.
  3. Lindstedt M, Borrebaeck CAK (2011) Pattern rules - biomarker signatures for sensitization as an alternative to animal testing. Biomarkers Med 5, 809-811.
  4. Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, Jirström K, Borrebaeck CAK, Ek S (2011)The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer 11, 405. (Abstract)
  5. Borrebaeck CAK, Wingren C (2011) Recombinant antibodies for the generation of antibody arrays. Methods Mol Biol 785, 247-262. (Abstract)
  6. Gunnarsson A, Dexlin-Mellby L,Wallin P, Svedhem S, Jönsson P, Wingren C, Höök, F (2011) Kinetics of ligand binding to membrane-receptors from equilibrium fluctuation analysis of single binding events. J Am Chem Soc 38, 14852-14855. (Abstract)
  7. Conrotto P, Andréasson U, Kuci V, Borrebaeck CAK, Ek S (2011) Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo. Mol Oncol 5, 527-537. (Abstract)
  8. Carlsson A, Wingren C, Kristensson M, Rose C, Fernö M, Olsson H, Jernström H, Ek S, Gustavsson E, Ingvar C, Ohlsson M, Peterson C, Borrebaeck CAK (2011) Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases. Proc Natl Acad Sci 108, 14252-14257. (Abstract)
  9. Johansson H, Lindstedt M, Albrekt AS, Borrebaeck CAK (2011) A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics 12, 399 (Abstract)
  10. Olsson N, Wingren C, Mattsson M, James P, O'Connell D, Nilsson F, Cahill DJ, Borrebaeck CAK (2011) Proteomic analysis and discovery using affinity proteomics and mass spectrometry. Mol Cell Proteomics 10, M110.003962. (Abstract)
  11. Welinder C, Baldetorp B, Borrebaeck C, Fredlund BM, Jansson B (2011) A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti tumour activity. Glycobiology 21, 1097-1107. (Abstract)
  12. Lundberg K, Broos S, Greiff L, Borrebaeck CAK, Lindstedt M (2011) Histamine H4 receptor antagonism inhibits allergen-specific T-cell responses mediated by human dendritic cells. Eur J Pharmacol 651, 197-204. (Abstract)
  13. Gustavsson E , Ek S, Steen J, Kristensson M, Älgenäs C, Uhlén M, Wingren C, Ottosson J, Hober S, Borrebaeck CAK (2011) Surrogate antigens as targets for proteome-wide binder selection. N Biotechnol 28, 302-311. (Abstract)
  14. Reinhard H, Le VTK, Ohlin M, Hengel H, Trilling M (2011) Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS ONE 6, e14532 (Abstract)
  15. Centlow M, Wingren C, Borrebaeck CAK, Brownstein MJ, Hansson SR (2011) Differential gene expression analysis of placentas with increased vascular resistance and preeclampsia using whole genome microarrays. J Pregnancy article ID 472354 (Abstract)
  16. Levin M, Tan LW, Baker L, Wormald PJ, Greiff L, Ohlin M (2011) Diversity of IgE-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis. Clin Exp Allergy 41, 811-820. (Abstract)
  17. Dexlin-Mellby L, Sandström A, Antberg L, Karlsson J, Hansson SR, Borrebaeck CAK, Wingren C (2011) Design of recombinant antibody microarrays for membrane protein profiling of cell lysates and tissue extracts. Proteomics 11, 1550-1554. (Abstract)
  18. Carlsson A, Wuttge DM, Ingvarsson J, Bengtsson AA, Sturfelt G, Borrebaeck CAK, Wingren C (2011) Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Mol Cell Proteomics 10, M110.005033 (Abstract)
  19. Magnusson K, de Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen, S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CAK, Navani S, Uhlén M, O’Connor DP, Jirström K, Pontén F (2011) SATB2 in combination with Cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surgical Pathol 35, 937-948. (Abstract)

2010

  1. Borrebaeck CAK, Wingren C (2010) Developing and applying recombinant antibody microarrays for high-throughput disease proteomics. Eur Pharm Rev 6, 45-49.
  2. Széles L, Póliska S, Nagy G, Szatmari I, Szanto A, Pap A, Lindstedt M, Santegoets SJ, Rühl R, Dezsö B, Nagy L (2010) Research resource: Transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol Endocrinol 24, 2218-2231. (Abstract)
  3. Dexlin-Mellby L, Sandström A, Centlow M, Nygren S, Hansson SR, Borrebaeck CAK, Wingren C (2010) Tissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays. Proteomics Clin Appl 4, 794-807. (Abstract)
  4. Håkansson M, Logan DT, von Schantz L, Nordberg Karlsson E, Ohlin M (2010) Non-specific CBM4-2 variant X-2 L110F – apo, xylopentaose, cellopentaose structures. MAX-Lab Activity Report 2010 (Eds. Johansson U, Lilja K, Nyberg A, Nyholm R), MAX-Lab, Lund, Sweden. pp 338-339. (report)
  5. Lundberg K, Greiff L, Borrebaeck CAK, Lindstedt M (2010) FcεRI levels and frequencies of peripheral blood dendritic cell populations in allergic rhinitis. Hum Immunol 71, 931-933. (Abstract)
  6. Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, Borrebaeck CAK, Ek S (2010) SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer 9, 187. (Abstract)
  7. Bourbeillon J, Orchard S, Benhar I, Borrebaeck C, de Daruvar A, Dübel S, Frank R, Gibson F, Gloriam D, Haslam N, Hiltker T, Humphrey-Smith I, Hust M, Juncker D, Koegl M, Konthur Z, Korn B, Krobitsch S, Muyldermans S, Nygren P-Å, Palcy S, Polic B, Rodriguez H, Sawyer A, Schlapshy M, Snyder M, Stoevesandt O, Taussig MJ, Templin M, Uhlén M, van der Maarel S, Wingren C, Hermjakob H, Sherman D (2010) Minimum Information about a Protein Affinity Reagent (MIAPAR). Nat Biotechnol 28, 650-653. (Abstract)
  8. Broos S, Lundberg K, Akagi T, Kadowaki K, Akashi M, Greiff L, Borrebaeck CAK, Lindstedt M (2010) Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy. Vaccine 28, 5075-5085. (Abstract)
  9. Jensen RL, Städe LW, Wimmer R, Stensballe A, Duroux M, Larsen KL, Wingren C and Duroux L (2010) Direct site-directed photocoupling of proteins onto surfaces coated with β-cyclodextrins. Langmuir 26, 11597-11604. (Abstract)
  10. Andréasson U, Edén P, Peterson C, Högerkorp CM, Jerkeman M, Andersen N, Berglund M, Sundström C, Rosenquist R, Borrebaeck CAK and Ek S (2010) Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples. Am J Hematol 85, 418-425. (Abstract)
  11. Sandquist D, Filonova L, von Schantz L, Ohlin M and Daniel G (2010) Microdistribution of xyloglucan in differentiating poplar cells. BioResources 5, 796-807. (pdf)
  12. Kobayashi N, Oyama H, Kato Y, Goto J, Söderlind E and Borrebaeck CAK (2010) Two-step in vitro antibody affinity maturation enables estradiol-17β assays with more than 10-fold higher sensitivity. Anal Chem 82, 1027-1038. (Abstract)
  13. Carlsson A, Persson O, Ingvarsson J, Widegren B, Salford L, Borrebaeck CAK and Wingren C (2010) Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients. Proteomics Clin Appl 4, 591-602. (Abstract)
  14. Gloriam DE, Orchard S, Bertinetti D, Björling E, Bongcam-Rudloff E, Bourbeillon J, Bradbury AR, de Daruvar A, Dübel S, Frank R, Gibson TJ, Haslam N, Herberg FW, Hiltke T, Hoheisel JD, Kerrien S, Koegl M, Konthur Z, Korn B, Landegren U, van der Maarel S, Montecchi-Palazzi L, Palcy S, Rodriguez H, Schweinsberg S, Sievert V, Stoevesandt O, Taussig MJ, Uhlén M, Wingren C, Gold L, Woollard P, Sherman DJ and Hermjakob H (2010) A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics 9, 1-10. (Abstract) [Epub ahead of print Aug 11, 2009]
  15. Persson O, Salford LG, Fransson J, Widegren B, Borrebaeck CAK and Holmqvist B (2010) Distribution, cellular localization and therapeutic potential of the tumor associated antigen Ku70/80 in glioblastoma multiforme. J Neurooncol 97, 207-215 (Abstract) [Epub ahead of print Oct 7, 2009]
  16. Gullfot F, Tan T-C, von Schantz L, Nordberg Karlsson E, Ohlin M, Brumer H and Divne C (2010) The crystal structure of XG-34, an evolved xyloglucan-specific carbohydrate binding module. Proteins 78, 785-789. (Abstract) (protein structure) [Epub ahead of print Oct 26, 2009]
  17. Persson H, Persson J, Danielsson L and Ohlin M (2010) Charges drive selection of specific antibodies by phage display. J Immunol Methods 353, 24-30. (Abstract) [Epub ahead of print Dec 1, 2009]
  18. Gustafsson E, Rosén A, Barchan K, van Kessel KPM, Haraldsson K, Lindman S, Forsberg C, Ljung L, Bryder K, Walse B, Haas P-J, van Strijp JAG and Furebring C (2010) Directed evolution of Chemotaxis Inhibitory Protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies. Protein Eng Des Sel 23, 91-101. (Abstract) [Epub ahead of print Dec 3, 2009]

2009

  1. Gustafsson E, Forsberg C, Haraldsson K, Lindman S, Ljung L and Furebring C (2009) Purification of truncated and mutated chemotaxis inhibitory protein of Staphylococcus aureus  - an anti-inflammatory protein. Protein Expres Purif 63, 95-101. (Abstract) [Epub ahead of print Oct 5, 2008]
  2. Larsson K, Lindstedt M, Lundberg K, Dexlin L, Wingren C, Korsgren M, Greiff L, Borrebaeck CAK (2009) CD4+ T-cells have a key instructive role in educating dendritic cells in allergy. Int Arch Allergy Immunol 149, 1-15. (Abstract) [Epub ahead of print Nov 26, 2008]
  3. Augustsson P, Persson J, Ekström S, Ohlin M and Laurell T (2009) Decomplexing biofluids using microchip based acoustophoresis. Lab Chip 9, 810 - 818. (Abstract) [Epub ahead of print Dec 1, 2008]
  4. Fransson J and Borrebaeck CAK (2009) Selection and characterization of antibodies from phage display libraries against internalizing membrane antigens. Methods Mol Biol 480, 1-15. (Abstract)
  5. Wingren C and Borrebaeck CAK (2009) Antibody-based microarrays. Methods Mol Biol 509, 57-84. (Abstract)
  6. Borrebaeck CAK and Wingren C (2009) Transferring proteomic discoveries into clinical practice. Expert Rev Proteomics 6, 11-13. (Abstract)
  7. Gustafsson E, Haas P-J, Walse B, Hijnen M, Furebring C, Ohlin M, van Strijp JAG and van Kessel KPM (2009) Identification of conformational epitopes for human IgG on chemotaxis inhibitory protein of Staphylococcus aureus. BMC Immunol 10, 13. (Abstract)
  8. Wingren C, James P and Borrebaeck CAK (2009) Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics 9, 1511-1517. (Abstract)
  9. Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannely G, O´Connor DP, Gallagher W, Kilpinen S, Kallioniemi OP, Jirström K, O´Herlihy C and Borrebaeck CAK (2009) The transcription factor Sox11 is a prognostic factor for Improved recurrence free survival in epithelial ovarian cancer. Eur J Cancer 45, 1510-1517. (Abstract)
  10. Nyström J, Hultenby K, Ek S, Sjölund J, Axelson H, Jirström K, Saleem MA, Nilsson K and Johansson ME (2009) CRIM1 is localized to the podocyte filtration slit diaphragm of the adult human kidney. Nephrol Dial Transplant 24, 2038-2044. (Abstract)
  11. Borrebaeck CAK and Wingren C (2009) Design of high-density antibody microarrays for disease proteomics: Key technological issues. J Proteomics 72, 928-935. (Abstract)
  12. Axelsson F, Persson J, Moreau E, Côté MH, Lamarre A and Ohlin M (2009) Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology. N Biotechnol 25, 429-436. (Abstract)
  13. Persson J, Bäckström M, Johansson H, Jirström K, Hansson GC and Ohlin M (2009) Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumour cells. Tumor Biol 30, 221-231. (Abstract)
  14. Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadström T and Borrebaeck CAK (2009) Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 94, 1563-1568. (Abstract)
  15. Brodin E, Ohlin M and Lindén J (2009)  Mentorskap i forskarutbildningen: doktoranders, mentorers och handledares syn på lärande i forskarutbildningen. In: Sonesson A and Amnér G (Eds.) Proceedings of Utvecklingskonferens 09, Lunds universitet, Lund, Sweden. pp 14-20.
  16. Andréasson U, Dictor M, Jerkeman M, Berglund M, Högerkorp C-M, Sundström C, Rosenquist R, Eden P, Borrebaeck CAK and Ek S (2009) Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumour cells. Am J Hematol 84, 803-808. (Abstract)
  17. Ellmark P, Ghatnekar-Nilsson S, Meister A, Heinzelmann H, Montelius L, Wingren C and Borrebaeck CAK (2009) Attovial-based antibody nanoarrays. Proteomics 9, 5406-5413. (Abstract)
  18. von Schantz L, Gullfot F, Scheer S, Filonova L, Cicortas Gunnarsson L, Flint JE, Daniel G, Nordberg-Karlsson E, Brumer H and Ohlin M (2009) Affinity maturation generates greatly improved xyloglucan-specific carbohydrate binding modules. BMC Biotechnol 9, 92. (Abstract)
  19. Hans Ulrich Weltzien HU, Emanuela Corsini E, Sue Gibbs S, Lindstedt M, Borrebaeck C, Budde P, Schulz-Knappe P, Thierse HJ, Martin SF and Roggen EL (2009)  Safe cosmetics without animal testing? Contributions of the EU Project Sens-it-iv. J Verbr Lebensm 4 (Suppl 2), S41–S48. (Abstract)

2008

  1. Ek S, Dictor M, Jerkeman M, Jirström K and Borrebaeck CAK (2008) Nuclear expression of the non-B cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 111, 800-805. (Abstract) [Epub ahead of print Oct 12, 2007]
  2. Dexlin L, Ingvarsson J, Frendéus B, Borrebaeck CAK and Wingren C (2008) Membrane protein profiling of intact cells using recombinant antibody microarrays. J Proteome Res 7, 319-327. (Abstract) [Epub ahead of print Nov 30, 2007]
  3. Ellmark P, Andersson H, Abayneh S, Fenyö EM and Borrebaeck CAK (2008) Identification of a strongly activating human anti-CD40 antibody that suppresses  HIV-1 infection. AIDS Res Hum Retroviruses 24, 367-373. (Abstract)
  4. Abayneh SA, Ellmark P, Karlsson U, Andersson H, Borrebaeck CAK, Karlsson I and Fenyö EM (2008) Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use. AIDS Res Hum Retroviruses 24, 447-452. (Abstract)
  5. Ellmark P, Woolfson A, Belov L and Christopherson RI (2008) The applicability of a cluster of differentiation monoclonal antibody microarrays to the diagnosis of human disease. In: Genomic protocols 2nd ed. (Eds. Starkey M and Elaswarapu R). Meth Mol Biol vol. 439, Humana Press, Totowa, NJ, USA, pp. 199-209. (Abstract)
  6. Andréasson U, Ek S, Merz H, Rosenquist R, Andersen N, Jerkeman M, Dictor M and Borrebaeck CAK (2008) B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule. Cancer Lett 259, 138-245. (Abstract) [Epub Dec 3, 2007]
  7. Ortega-Paino E, Fransson J, Ek S and Borrebaeck CAK (2008) Functionally-associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference. Blood 111, 1617-1624. (Abstract) [Epub Nov 16, 2007]
  8. Wingren C and Borrebaeck CAK (2008) Antibody microarray analysis of directly labelled complex proteomes. Curr Opin Biotechnol 19, 55-61. (Abstract)
  9. Carlsson A, Wingren C, Ingvarsson J, Ellmark P, Baldertorp, Fernö M, Olsson H and Borrebaeck CAK (2008) Serum protein profiling of metastatic breast cancer using recombinant antibody microarrays". Eur J Cancer 44, 472-480. (Abstract) [Epub Dec 31, 2007]
  10. Persson H, Flicker S, Karbalaei Sadegh M, Valenta R, Greiff L and Ohlin M (2008) A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2. Mol Immunol 45, 2715-2720. (Abstract)
  11. Ellmark P, Högerkorp CM, Ek S, Belov L, Berglund M, Christopherson RI, and Borrebaeck CAK (2008) Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Lett 265, 98-106. (Abstract)
  12. Ingvarsson J, Wingren C, Carlsson A, Ellmark P, Wahren B, Engström G, Harmenberg U, Krogh M, Peterson C, Borrebaeck CAK (2008) Detection of pancreatic cancer using antibody microarray-based serum protein profiling. Proteomics 8, 2211-2219. (Abstract) (journal cover )
  13. Wingren C and Borrebaeck CAK (2008) Antibody microarray-based proteomics: High-throughput application. Bioforum Europe. 2008, 46-47.
  14. Wingren C and Borrebaeck CAK Antibody microarray-based screening:  Label-dependent vs. Label-free detection. Scr Trend Drug Discov 2/2008, 12-14.
  15. Lundberg K, Lindstedt M, Larsson K, Dexlin L, Wingren C, Ohlin M,
    Greiff L and Borrebaeck CAK (2008) Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4. Clin Immunol 128, 358-365. (Abstract)
  16. Santegoets S, Gibbs S, Kroeze K, van de Ven R, Scheper RJ, Borrebaeck CAK, de Gruijl TD and Lindstedt M (2008) Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol 84, 143-151. (Abstract)
  17. Persson H, Wallmark H, Ljungars A, Hallborn J and Ohlin M (2008) In vitro evolution of an antibody fragment population to find high affinity hapten binders. Protein Eng Des Sel 21, 485-493. (Abstract)
  18. Ohlin M (2008) Handledning, återkoppling och bedömning i utbildning på forskarnivå. Finns det ett behov av förändring? In: Sonesson A and Hedberg M (Eds.) Proceedings NU2008. CED, Lund, Sweden. pp 117-119. (Full text)
  19. Persson J, Augustsson P, Laurell T and Ohlin M (2008) Acoustic microfluidic chip technology to facilitate automation of phage display selection. FEBS J 275, 5657-5666. (Abstract) (journal cover )
  20. Sekula S, Fuchs J, Weg-Remers S, Nagel P, Schuppler S, Fragala J, Theilacker N, Franzreb M, Wingren C, Ellmark P, Borrebaeck CAK, Mirkin CA, Fuchs H and Lenhert S (2008) Multiplexed lipid dip-pen nanolithography on subcellular scales for the templating of functional proteins and cell culture. Small 4, 1785-1793. (Abstract) (journal cover )
  21. Wingren C and Borrebaeck CAK (2008) Protein microarray technologies for detection and identification of bacterial and protein analytes. In: Zourob M, Elwary S and Turner A (Eds.) Principles of bacterial detection: Biosensors, recognition receptors and microsystems. Springer, Heidelberg, Germany. pp 715-729.
  22. Naurin S, Bensch S, Hansson B, Johansson T, Clayton DF, Albrekt A-S, von Schantz T and Hasselqvist D (2008) A microarray for large-scale genomic and transcriptional analyses of the zebra finch (Taeniopygia guttata) and other passerines. Mol Ecol Resources 8, 275-281 (Abstract)
  23. Håkansson M, Logan DT, von Schantz L, Nordberg Karlsson E, Ohlin M (2008) Engineered CBM4-2 variant X-2 – apo, xylotetrose, xylopentose structures. MAX-Lab Activity Report 2008 (Eds. Johansson U, Nyberg A, Nyholm R, Ullman H), MAX-Lab, Lund, Sweden. pp 368-369. (report)

2007

  1. Barrios Y, Knör S, Lantto J, Mach M and Ohlin M (2007) Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties. Mol Immunol 44, 680-690. [Epub ahead of print July 7, 2006] (Abstract)
  2. Persson H and Ohlin M (2007) Exploring central and peripheral diversity in antibody evolution. Mol Immunol 44, 2729-2736. (Abstract)
  3. Ghatnekar-Nilsson S, Dexlin L, Wingren C, Montelius L and Borrebaeck CAK (2007) Design of atto-vial based recombinant antibody arrays combined with a planar wave guide detection system. Proteomics 7, 540-547. (Abstract)
  4. Taussig MJ, Stoevesandt O, Borrebaeck CAK, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dübel S, Eichler J, Frank R, Gibson TJ, Gloriam D, Gold L, Herberg FW, Hermjakob H, Hoheisel JD, Joos TO, Kallioniemi O, Koegll M, Konthur Z, Korn B, Kremmer E, Krobitsch S, Landegren U, van der Maarel S, McCafferty J, Muyldermans S, Nygren PÅ, Palcy S, Plückthun A, Polic B, Przybylski M, Saviranta P, Sawyer A, Sherman DJ, Skerra A, Templin M, Ueffing M, Uhlén M (2007) ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods 4, 13-17. (Abstract)
  5. Zhou Y, Xu H, Dahlin A, Vallkil J, Borrebaeck CAK, Wingren C, Liedberg B and Höök F. (2007) Quantitative interpretation of of gold nanoparticle-based bioassays designed for detection of immuno-complex formation. Biointerphases 2, 6-15 (Abstract).
  6. Wingren C and Borrebaeck CAK (2007) Antibody microarray-based proteomics. High Throughput Application. Bioforum Europe 2007, 34-35.
  7. Cicortas Gunnarsson L, Montanier C, Tunnicliffe RB, Williamson MP, Gilbert HJ, Nordberg Karlsson E and Ohlin M (2007) Novel xylan-binding properties of an engineered family 4 carbohydrate-binding module. Biochem J 406, 209-214. (Abstract)
  8. Persson H, Karbalaei Sadegh M, Greiff L and Ohlin M (2007) Delineating the specificity of an IgE-encoding transcriptome. J Allergy Clin Immunol 120, 1186-1192. (Abstract) (see comment in the journal's Editors' choice section)
  9. Ingvarsson J, Larsson A, Sjöholm AG, Truedsson L, Jansson B, Borrebaeck CAK and Wingren C (2007) Design of Recombinant Antibody Microarrays for Serum Protein Profiling: Targeting of Complement Proteins. J Proteome Res 6, 3527-3536 (Abstract)
  10. Ohlin M (2007) Formativ examination i utbildning på forskarnivå – möjligheter till förändring. In: Proceedings of Utvecklingskonferens LU 2007, Lund University, Lund, Sweden. (in Swedish) (pdf-file) (complete conference proceedings)
  11. Wingren C, Ingvarsson J, Dexlin L, Szul D and Borrebaeck CAK (2007) Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labeling-tag and solid support. Proteomics 7, 3055-3065. (Abstract)
  12. Augustsson P, Persson J, Ohlin M and Laurell T (2007) On-chip affinity selection of antibodies using ultrasonic standing waves. In: Viovy J-L, Tabeling P, Descroix S and Malaquin L (Eds.) Micro Total Analysis Systems 2007. Proceedings of µTAS 2007. 11th International Conference on Miniaturized Systems for Chemistry and Life Sciences, Vol. 2. Chemical and Biological Microsystems Society, San Diego, CA, USA, pp. 1810-1812.
  13. Wingren C and Borrebaeck CAK (2007) Progress in miniaturization of protein arrays - a step closer to high-density nanoarrays. Drug Discov Today 12, 813-819. (Abstract)
  14. Borrebaeck CAK and Wingren C (2007) High-throughput proteomics using antibody microarrays: an update. Expert Rev Mol Diagn 7, 673-686. (Abstract)
  15. Filonova L, Cicortas Gunnarsson L, Daniel G and Ohlin M (2007) Synthetic xylan-binding modules for mapping of pulp fibres and wood sections. BMC Plant Biol 7, 54. (Abstract)
  16. Ek S and Borrebaeck CAK (2007) Parallel gene expression profiling of Mantle cell lymphoma - How do we transform 'omics data into clinical practice. Curr Genomics 8, 171-179. (Abstract)
  17. Ohlin M (2007) Bedömning, återkoppling och examination i utbildning på forskarnivå - vad är i fokus? Lärande i LTH 2, 2-3. (in Swedish) (pdf-file)
  18. Axelsson F, Adler SP, Lamarre A and Ohlin M (2007) Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines. Vaccine 26, 41-46. (Abstract)
  19. Duroux M, Skovsen E, Neves-Petersen MT, Duroux L, Gurevich L, Borrebaeck CAK, Wingren C and Petersen SB (2007) Light-induced immobilisation of biomolecules as an attractive alternative to microdroplet dispensing-based arraying technologies. Proteomics 7, 3491 - 3499 (2008: 8, 1113).
  20. Duroux M, Gurevich L, Neves-Petersen MT, Skovsen E, Duroux L, Borrebaeck CAK, Wingren C and Petersen SB (2007) Using light to bioactivate surfaces: A new way of creating oriented, active immunobiosensors. Appl Surf Sci 254, 1126-1130. (Abstract)

2006

  1. Roggen EL, Lindstedt M, Borrebaeck C and Verheyen GR. (2006) Interactions between dendritic cells and epithelial cells in allergic disease. Toxicol Lett 162, 71-82. [Epub ahead of print Nov 21, 2005] (Abstract)
  2. Ingvarsson J, Lindstedt M, Borrebaeck CAK and Wingren C (2006) One-step fractionation of complex proteomes enables detection of low abundant analytes using antibody-based microarrays. J Proteome Res 5, 170-176. (Abstract)
  3. Ek S, Björck E, Högerkorp C-M, Nordenskjöld M, Porwit-MacDonald A, Borrebaeck CAK (2006) Mantle cell lymphomas acquire expression of CCL4, CCL5 and 4-1BB implicated in cell survival. Int J Cancer 118, 2092-2097 [Epub ahead of print Nov 14, 2005] (Abstract)
  4. Larsson K, Lindstedt M and Borrebaeck CAK (2006) Functional and transcriptional profiling of MUTZ-3. A myeloid cell line acting as a model for dendritic cells. Immunology 117, 155-166. (Abstract)
  5. Cicortas Gunnarsson L, Dexlin L, Nordberg Karlsson E, Holst O and Ohlin M (2006) Evolution of a carbohydrate binding module into a protein-specific binder. Biomol Eng 23, 111-117. (Abstract)
  6. Cicortas Gunnarsson L, Nordberg Karlsson E, Andersson M, Holst O and Ohlin M (2006) Molecular engineering of a thermostable carbohydrate-binding module. Biocatal Biotransfor 24, 31-37. (Abstract)
  7. Fransson J, Tornberg U-K, Borrebaeck CAK, Carlsson R, and Björn Frendéus B (2006) Rapid induction of apoptosis in B cell lymphoma by functionally isolated human antibodies. Int J Cancer 119, 349-358. (Abstract)
  8. Persson H, Lantto J and Ohlin M (2006) Creating a focused antibody library for improved hapten recognition. J Mol Biol 357, 607-620. (Abstract)
  9. Johansson R, Ohlin M, Jansson B and Ohlson S (2006) Transiently binding antibody fragments against Lewis x and sialyl-Lewis x. J Immunol Methods 312, 20-26. (Abstract)
  10. Larsson A, Peng S, Persson H, Rosenblom J, Abrams WR, Wassberg E, Thelin S, Sletten K, Gerwins P and Westermark P (2006) Lactadherin binds to elastin - a starting point for amyloid formation? Amyloid 13, 78-75. (Abstract)
  11. Ek S, Andréasson U, Hober S, Kampf C, Pontén F, Uhlén M, Merz H, Borrebaeck CAK (2006) From gene expression analysis to tissue microarrays - a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol Cell Proteomics 5, 1072-1081 (Abstract)
  12. Karlsson F, Malmborg-Hager, A-C and Borrebaeck CAK (2006) Escherichia coli TolA tolerates multiple amino acid substitutions as revealed by screening randomised variants for membrane integrity and phage receptor function. FEMS Microbiol Lett 259, 81-88. (Abstract)
  13. Wingren C and Borrebaeck CAK (2006) Recombinant antibody microarrays: key technological issues. Scr Trend Drug Discov 02/2006, 13-15. (pdf-file)
  14. Steinhauer C, Wingren C, Khan F, He M, Taussig M and Borrebaeck CAK (2006) Improved affinity coupling for antibody microarrays: Engineering of double-(his)6-tagged single framework recombinant antibody fragments. Proteomics 6, 4227-4234. (Abstract)
  15. Wingren C (2006) Screening Europe 2006, Prague, Czech Republic, IDDB Meeting Report. In Investigational Drug DataBase (IDdb) (www.iddb.com). Thompson Scientific, Philadelphia, PA, USA.
  16. Johansson R, Cicortas Gunnarsson L, Ohlin M and Ohlson S (2006) Thermostable carbohydrate-binding modules in affinity chromatography. J Mol Recognit 19, 275-281. (Abstract)
  17. Andréasson U, Flicker S, Lindstedt M, Valenta R, Greiff L, Korsgren M, Borrebaeck CAK and Ohlin M (2006) The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution. J Mol Biol 362, 212-227. (Abstract)
  18. Fransson J and Borrebaeck CAK (2006) The nuclear DNA repair protein Ku70/80 is a tumor-associated antigen displaying rapid receptor mediated endocytosis. Int J Cancer 119, 2492-2496. (Abstract)
  19. Wingren C (2006) First world congress meeting on OncoProteomics April 27-28, 2006, CA, USA. Expert Rev Proteomics 3, 267-270. (Abstract)
  20. Ellmark P, Ingvarsson J, Carlsson A, Lundin SB, Wingren C and Borrebaeck CAK (2006) Identification of protein expression signatures associated with H. pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 5, 1638-1646. (Abstract)
  21. Borrebaeck CAK (2006) Antibody microarray-based oncoproteomics. Expert Opin Biol Ther 6, 833-838. (Abstract)
  22. Högerkorp C-M and Borrebaeck CAK (2006) The human CD77- B cell population represents a heterogeneous subset of cells comprising centroblasts, centrocytes and plasmablasts, prompting phenotypical revision. J Immunol 177, 4341-4349. (Abstract)
  23. Cicortas Gunnarsson L, Zhou Q, Montanier C, Nordberg Karlsson E, Brumer H III and Ohlin M (2006) Engineered xyloglucan specificity in a carbohydrate-binding module. Glycobiology 16, 1171-1180. (Abstract)
  24. Woolfson A, Ellmark P, Chrisp JS, A Scott M and Christopherson RI (2006) The application of CD antigen proteomics to pharmacogenomics. Pharmacogenomics 7, 759-771. (Abstract)
  25. Persson J and Ohlin M (2006) Antigens for the selection of pan-VNTR (variable number of tandem repeats) motif-specific human antibodies against Mucin-1. J Immunol Methods 316, 116-124. (Abstract)
  26. Wingren C and Borrebaeck CAK (2006) Antibody microarrays: current status and key technological advances. OMICS 10, 411-427. (Abstract)

2005

  1. Steinhauer C, Ressin A, Marko-Varga G, Laurell T, Borrebaeck CAK and Wingren C (2004) Biocompatibility of surfaces for antibody microarrays: Design of macroporous silicon substrates. Anal Biochem  341, 204-213. (Abstract)
  2. Björck E, Ek S, Landgren O, Jerkeman M, Ehinger M, Björkholm M, Borrebaeck CAK, Porwit-Macdonald A and Nordenskjöld M (2005) High expression of cyclin B1 predicts a favorable outcome of patients with follicular lymphoma. Blood 105, 2908-2915. (Abstract)
  3. Wingren C, Steinhauer C, Ingvarsson J, Persson E, Larsson K and Borrebaeck CAK. (2005) Microarrays based on affinity-tagged scFv antibodies: sensitive detection of analyte in complex proteomes. Proteomics 5, 1281-1291. (Abstract)
  4. Lindstedt M, Schiött Å, Johnsen CR, Roggen E, Johansson-Lindbom B and Borrebaeck CAK (2005) Individuals with occupational allergy to detergent enzymes display a differential transcriptional regulation and cellular immune response. Clin Exp Allergy 35, 199-206. (Abstract)
  5. Ek S, Ortega E and Borrebaeck CAK (2005) Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma. Leuk Res 29, 205-213. (Abstract)
  6. Lindstedt M, Schiött Å, Bengtsson A, Larsson K, Korsgren M, Greiff L, Borrebaeck CAK (2005) Genomic and functional delineation of dendritic cells and memory T-cells derived from grass pollen-allergic patients and healthy individuals. Int Immunol 17, 401-409. (Abstract)
  7. Karlsson F, Malmborg-Hager A-M, Albrekt A-S and Borrebaeck CAK (2005) Genome-wide comparison of phage M13 infected vs. uninfected Escherichia coli. Can J Microbiol 51, 29-35. (Abstract)
  8. Persson J, Lantto J, Drakenberg T and Ohlin M (2005) Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicity. Mol Immunol 42, 1321-1330. (Abstract)
  9. Larsson C, Bramfeldt H, Wingren C, Borrebaeck CAK, Höök F (2005) Gravimetric antigen detection utilizing antibody-modified lipid bilayers. Anal Biochem 345, 72-80. (Abstract)
  10. Lindstedt M, Lundberg K and Borrebaeck CAK (2005) Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J Immunol 175, 4839-4846. (Abstract)
  11. Matsusaki M, Larsson K, Akagi T, Lindstedt M, Akashi M, and Borrebaeck CAK (2005) Nanosphere induced gene expression in human dendritic cells. Nano Lett 5, 2168-2173. (Abstract)

Publications 2000-2004

Publications 1990-1999

Theses

Page Manager: Mats Ohlin
Webmaster: webmaster@lth.se
Last updated: 2012-09-18